UEL’s ambition is to become London’s leading university for civic engagement. We are a vibrant and diverse university located in the heart of east London. Our new corporate plan sets an ambitious agenda for our future success and growth which focuses on the delivery of high quality teaching and learning, and excellence in research.
Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's supplemental Biologics License Application (sBLA) for the expanded use of Enbrel® (etanercept) to treat pediatric patients with chronic severe plaque psoriasis.